Use of Moisturizers and Lubricants for Vulvovaginal Atrophy

• Autor(a) principal: Sarmento, AC
• Data de Publicação: 2021
• Outros Autores: Kamilos, MF, Costa, AP, Vieira-Baptista, P, Eleutério, J, Gonçalves, AK
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10400.26/42149
• topic: Atrofia/tratamento farmacológico; Doenças Vaginais/tratamento farmacológico; Doenças da Vulva/tratamento farmacológico; Lubrificantes; Atrophy/drug therapy; Vaginal Diseases/drug therapy; Vulvar Diseases/drug therapy; Lubricants

The estrogen decrease in postmenopausal women results in functional and anatomical changes in the genitourinary tract. The most prevalent and bothersome symptoms are vaginal dryness, dyspareunia, and reduced lubrication, which can significantly affect the quality of life of these women, principally those who are sexually active. Hormonal therapy with local estrogens is generally considered the "gold standard." However, there are cases in which there are clinical concerns about its use or women opt for non-hormonal options. Thus, safe and effective non-hormonal options are needed to improve symptoms in these women. Moisturizers and lubricants are first-line therapy for breast cancer survivors.